PET, MRI, and simultaneous PET/MRI in the development of diagnostic and therapeutic strategies for glioma

- PET and MRI play a pivotal role in the development of therapeutic strategies for glioma.
- Preclinical PET/MRI has the potential to be central to the future of drug development for glioma.
- PET/MRI allows simultaneous imaging of therapeutic platforms and multiple aspects of cancer.
- PET/MRI could affect a paradigm shift in the drug development process.